About this episode

This episode discusses the evolving care for multiple myeloma, emphasizing the importance of teamwork and informed decision-making for patients and caregivers.

Multiple myeloma care is evolving faster than ever, with new therapies, treatment strategies, and possibilities emerging at an unprecedented pace. In this episode, hematologist Dr. Devarakonda and Kathy Giusti, founder of the Multiple Myeloma Research Foundation, come together for a candid, practical conversation about what this rapid progress means for patients, caregivers, and providers. They explore why where you’re treated matters , how timing, sequencing, and dosing decisions shape outcomes , and what it takes to be an informed patient in today’s complex care environment . Through real-world stories and clinical insight, the conversation highlights the importance of collaboration between community and academic care teams, the growing role of the patient voice in decision-making, and the need to balance cutting-edge treatment with quality of life. Whether newly diagnosed or navigating later lines of therapy, this episode offers practical guidance for making confident, informed decisions in multiple myeloma care. Key Takeaways Multiple myeloma is increasingly treatable, with patients living longer than ever. Advances in therapy are leading to remission for many patients and…

Topics covered

• multiple myeloma
• treatment strategies
• patient care
• teamwork in healthcare
• clinical insights
• patient voice
• quality of life

Keywords

• multiple myeloma
• treatment
• care team
• patient decisions
• survival outcomes
• therapy advancements
• caregiver involvement

More episodes of HemeTalks: Conversations in Hematology Education

• Atención del Mieloma Múltiple: Oportunidad, Trabajo en Equipo y Tratamiento · May 21, 2026 · 22 min

Explore listener stats, chart rankings, contacts and more on the HemeTalks: Conversations in Hematology Education podcast page.